Martinrea International (MRE) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
28 Nov, 2025Executive summary
Q1 2025 sales were $1,168.2 million, down 11.8% year-over-year, with production sales at $1,125.7 million and tooling sales at $42.6 million.
Adjusted EBITDA was $140.9 million (12.1% margin), and adjusted operating income was $61.9 million (5.3% margin), both down year-over-year but improved sequentially from Q4 2024.
Adjusted EPS was $0.41, down from $0.62 year-over-year, impacted by lower operating income, FX losses, and a higher effective tax rate.
Free cash flow before IFRS 16 lease payments was negative $25.4 million, reflecting seasonal working capital build.
New business awards totaled $60 million in Q1 and $260 million over the last four quarters, including contracts with GM, Mercedes, Volvo, and Volvo Truck.
Financial highlights
Production sales decreased 10.5% year-over-year, mainly due to OEM inventory correction in North America.
Tooling sales dropped 35.9% year-over-year.
Adjusted operating income margin was 5.3%, down 70 basis points year-over-year.
Net debt (excluding IFRS 16) increased by $51 million to $865 million, with a net debt-to-adjusted EBITDA ratio of 1.64.
Dividend of $0.05 per share declared, payable July 15, 2025.
Outlook and guidance
2025 outlook calls for sales of $4.8–$5.1 billion, adjusted operating income margin of 5.3%–5.8%, and free cash flow of $125–$175 million.
Guidance excludes potential impacts from new tariffs or further government policy changes.
Management expects free cash flow and leverage ratios to improve as the year progresses, barring significant tariff impacts.
Cash restructuring costs anticipated at $55 million in 2025.
Industry forecasts have been revised downward, with North American light vehicle production now expected at 14 million units for 2025.
Latest events from Martinrea International
- Record Free Cash Flow and margin gains in 2025 set the stage for continued growth and expansion.MRE
Q4 20255 Mar 2026 - Record Q2 adjusted EBITDA, strong cash flow, and stable 2024 outlook despite industry headwinds.MRE
Q2 20242 Feb 2026 - Q3 saw lower sales and earnings but stronger margins, cash flow, and improved leverage.MRE
Q3 202414 Jan 2026 - Impairments and lower sales drove a net loss, but Free Cash Flow and margins remained resilient.MRE
Q4 20243 Dec 2025 - Margins and free cash flow improved in Q2 2025, with 2025 guidance reaffirmed.MRE
Q2 202523 Nov 2025 - Margins and adjusted EPS improved in Q3 2025 despite lower sales and free cash flow.MRE
Q3 202515 Nov 2025